Vertiv Holdings Co Work in process increased by 22.2% to $269.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.2%, from $300.10M to $269.50M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 19.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $151.30M | $107.30M | $105.00M | $148.50M | $163.80M | $175.10M | $168.30M | $171.20M | $170.20M | $165.00M | $138.40M | $169.00M | $200.20M | $270.80M | $278.90M | $300.10M | $259.20M | $214.90M | $220.50M | $269.50M |
| QoQ Change | — | -29.1% | -2.1% | +41.4% | +10.3% | +6.9% | -3.9% | +1.7% | -0.6% | -3.1% | -16.1% | +22.1% | +18.5% | +35.3% | +3.0% | +7.6% | -13.6% | -17.1% | +2.6% | +22.2% |
| YoY Change | — | — | — | — | +8.3% | +63.2% | +60.3% | +15.3% | +3.9% | -5.8% | -17.8% | -1.3% | +17.6% | +64.1% | +101.5% | +77.6% | +29.5% | -20.6% | -20.9% | -10.2% |
| % of Inventories | 27.4% | 18.6% | 17.0% | 19.2% | 20.6% | 21.8% | 20.5% | 18.9% | 18.5% | 17.9% | 15.7% | 17.1% | 18.1% | 21.6% | 22.4% | 21.7% | 18.3% | 15.0% | 15.1% | 14.7% |
| Share Change | — | -8.9pp | -1.5pp | +2.1pp | +1.4pp | +1.2pp | -1.3pp | -1.5pp | -0.5pp | -0.6pp | -2.3pp | +1.5pp | +1.0pp | +3.4pp | +0.8pp | -0.7pp | -3.4pp | -3.4pp | +0.2pp | -0.4pp |